Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5951)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through Aug 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fouad M, El Kassas M, Ahmed E, El Sheemy R. Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients. World J Hepatol 2021; 13(11): 1743-1752 [PMID: 34904042 DOI: 10.4254/wjh.v13.i11.1743] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1743.htm |
| Number | Citing Articles |
| 1 |
Mohamed Elgazzar, Tary Salman, Eman Abdelsameea, Mohamed Akl, Nabil Omar, Mohamed Abdel-Samiee, Shrif Abas, Mohmoud Elsakhawy, Ahmed Elsherif, Ibrahim Abdelkader, Dina Elazab, Nermine Ehsan, Mohamed Mohamady, Mohamed El-Kassas, Hazem Metwaly Omar. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01249-4
|
| 2 |
Nahed A Makhlouf, Ahmed Abu-Elfatth, Tasneem Khaled, Mohamed El-Kassas. The Interplay Between Schistosomiasis and Hepatitis C Virus: Battling on Two Fronts. Infectious Diseases & Immunity 2024; 4(4): 187 doi: 10.1097/ID9.0000000000000137
|
| 3 |
Randa Salah Abdelmoneim, Fathalla Sedki, Mohamed Fathy Bakosh. Changes in the presentation and characteristics OF HCV related hepatocellular carcinoma in the era of direct acting antiviral therapy: A retrospective study. Clinics and Research in Hepatology and Gastroenterology 2025; 49(4): 102567 doi: 10.1016/j.clinre.2025.102567
|
| 4 |
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053
|
| 5 |
Kazuto Tajiri, Hiroyuki Ito, Kengo Kawai, Yoshiro Kashii, Yuka Hayashi, Aiko Murayama, Masami Minemura, Terumi Takahara, Yukihiro Shimizu, Ichiro Yasuda. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma. World Journal of Hepatology 2022; 14(6): 1190-1199 doi: 10.4254/wjh.v14.i6.1190
|
| 6 |
Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot. Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates. Cancers 2022; 14(7): 1684 doi: 10.3390/cancers14071684
|
| 7 |
Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, Joanna Jabłońska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało. Differences in the course of hepatocellular carcinoma depending on the DAA treatment. Prospects in Pharmaceutical Sciences 2024; 22(3): 114 doi: 10.56782/pps.236
|
| 8 |
Rania Lithy, Mohamed Kohla, Hossam Dabees, Hend Ibrahim Shousha, Ehab Fawzy, Eman M. F. Barakat, Mohamed El-Kassas, Mona Shoukry Aziz, Eman Elkhateeb, Ashraf Omar Abdelaziz, Mohamed Omar Abdelmalek, Ali Azmy, Ahmed Tawheed, Reem Abdelghafour, Hossam Taha, Mohamed Mahmoud Nabeel, Mohamed A. Medhat, Dalia Ghoraba, Hamdy Sayed, Anwar Nassief, Mostafa Elhelbawy, Tamer Elbaz, Ahmed Radwan, Safaa Ragab Askar, Eman Marwan, Eman Rewisha, Ahmed Hosni Abdelmaksoud, Sayed Hassan Ahmed, Nevien Fouad Elfouly, Nermeen Abdeen, Ahmed Ramadan, Asmaa A. Abdeltawab, Mostafa Abd Alfattah Shamkh, Yasser Arafat Abdelrazek, Ammar Alrajhi, Sayed Ahmed Sayed, Ahmed A. Sleem, Rasha Salah Hussein, Allam Elsayed Allam, Omnia A. Seyam, Mohamed Said. Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00448-6
|